GlassScriptPhysician profile
Howard A Glick
NPI 1790798965
$2,881.90
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,856 · 2020: $388 · 2021: $186 · 2022: $429 · 2023: $23.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $931.35 | 2019-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $357.23 | 2019-2021 | |
| Lundbeck LLC | $309.12 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $266.65 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $219.78 | 2019-2022 | |
| Neos Therapeutics, LP | $187.76 | 2019-2020 | |
| Allergan, INC. | $180.27 | 2019-2020 | |
| Alkermes, INC. | $89.79 | 2022 | |
| Tris Pharma INC | $81.94 | 2019-2020 | |
| Shire North American Group INC | $64.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.79 | 2019 | |
| Sunovion Pharmaceuticals INC. | $30.10 | 2019 | |
| Bausch Health US, LLC | $25.23 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $19.78 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.66 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $12.64 | 2019 | |
| Corium, LLC | $12.38 | 2022 | |
| Owp Pharmaceuticals, INC. | $11.93 | 2019 | |
| Adlon Therapeutics L.P. | $11.14 | 2020 | |
| Alfasigma USA, INC. | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Glick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.